Novartis AGNVSNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
28.11%
↑ 226% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
8.63%
Historical baseline
PeriodValue
202528.11%
202417.94%
2023-2.43%
2022-4.14%
202113.10%
2020-2.67%
20194.13%
201810.55%
201714.88%
20166.84%